Mepolizumab: A New Hope for Severe Eosinophilic Asthma
Imagine having asthma so severe that regular treatments just don't cut it. This is where mepolizumab comes into play. This medication is part of a new wave of biologic therapies that target interleukin-5 (IL-5), a protein involved in the body's inflammatory response. As more research delves into IL-